These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1392 related items for PubMed ID: 1622631

  • 1. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV, Pike MC.
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [Abstract] [Full Text] [Related]

  • 2. Sex steroids and breast cancer prevention.
    Spicer DV, Pike MC.
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 4. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR, Gadducci A, Gambacciani M.
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [Abstract] [Full Text] [Related]

  • 5. Does HRT modify risk of gynecological cancers?
    Schneider HP, Birkhauser M.
    Int J Fertil Menopausal Stud; 1995 Sep; 40 Suppl 1():40-53. PubMed ID: 7581588
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Contraception and cancer prevention.
    Ursin G, Spicer DV, Pike MC.
    Adv Contracept Deliv Syst; 1994 Sep; 10(3-4):369-86. PubMed ID: 12287845
    [Abstract] [Full Text] [Related]

  • 8. Epidemiologic analysis of breast and gynecologic cancers.
    Hulka BS.
    Prog Clin Biol Res; 1997 Sep; 396():17-29. PubMed ID: 9108587
    [Abstract] [Full Text] [Related]

  • 9. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L.
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [Abstract] [Full Text] [Related]

  • 10. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC.
    J Natl Cancer Inst; 1994 Mar 16; 86(6):431-6. PubMed ID: 8120917
    [Abstract] [Full Text] [Related]

  • 11. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE.
    Acta Endocrinol (Copenh); 1991 Mar 16; 125 Suppl 1():13-26. PubMed ID: 1801500
    [Abstract] [Full Text] [Related]

  • 12. Progestogen deficiency and endometrial cancer risk.
    Schindler AE.
    Maturitas; 2009 Apr 20; 62(4):334-7. PubMed ID: 19231117
    [Abstract] [Full Text] [Related]

  • 13. [Oral contraception and its beneficial gynecological effects].
    Belaisch J, Hommais-loufrani B.
    Fertil Contracept Sex; 1988 Mar 20; 16(3 Suppl):3-7. PubMed ID: 12282188
    [Abstract] [Full Text] [Related]

  • 14. Use of HRT and the subsequent risk of cancer.
    Beral V, Banks E, Reeves G, Appleby P.
    J Epidemiol Biostat; 1999 Mar 20; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [Abstract] [Full Text] [Related]

  • 15. Reducing cancer risk in women through lifestyle-mediated changes in hormone levels.
    Pike MC.
    Cancer Detect Prev; 1990 Mar 20; 14(6):595-607. PubMed ID: 2257556
    [Abstract] [Full Text] [Related]

  • 16. Contraception and the big "C".
    Chandran R.
    Malays J Reprod Health; 1992 Jun 20; 10(1):1-5. PubMed ID: 12345024
    [Abstract] [Full Text] [Related]

  • 17. Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer.
    Spicer DV, Pike MC, Pike A, Rude R, Shoupe D, Richardson J.
    Contraception; 1993 May 20; 47(5):427-44. PubMed ID: 8390340
    [Abstract] [Full Text] [Related]

  • 18. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC.
    Contracept Fertil Sex (Paris); 1985 Jan 20; 13(1 Suppl):329-38. PubMed ID: 12280203
    [Abstract] [Full Text] [Related]

  • 19. [Cancer risk under hormone therapy].
    Lauritzen C.
    Ther Umsch; 1994 Nov 20; 51(11):755-66. PubMed ID: 7839334
    [Abstract] [Full Text] [Related]

  • 20. Contraception for the perimenopausal patient.
    Upton GV.
    Obstet Gynecol Clin North Am; 1987 Mar 20; 14(1):207-27. PubMed ID: 3306520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.